Endocrine Board Review 2020 Session Recordings

Test yourself and hear from the experts with the complete Endocrine Board Review 2020 Session Recordings experience. Endocrine Board Review 2020 Session Recordings contains recorded presentations in which experts review 220 case questions in a mock exam format. The online mock exam presentations provide the perfect complement to test your knowledge on core principles and challenges across the breadth of endocrinology. This product is ideal for those seeking the full learning experience as they prepare for the endocrine board exam or for those that simply want to stay up to date.


Endocrine Board Review 2020 Session Recordings will be available approximately 3 weeks following the live conference that will be held September 16-18, 2020. EBR 12th Edition Bundle (2020) combines the self-study book and online presentations in a convenient and complementary learning experience. The bundle includes the EBR 12th Edition (2020) self-study book with 220 clinical case questions as well as access to recorded presentations in Endocrine Board Review 2020 Session Recordings in a mock-exam format. 

  • Endocrine Board Review 2020 Session Recordings will be available approximately 3 weeks following the live conference (held September 16-18, 2020)
  • EBR 12th Edition (2020) self-study book will be shipped directly to purchasers

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Target Audience

This activity will be of substantial interest to physicians and endocrine fellows preparing for the ABIM Endocrinology, Diabetes, & Metabolism Board Certification Exam or for those that simply want to stay up to date and improve their practice skills through knowledge assessment of diagnosis, treatment, and management of endocrine conditions.

Learning Objectives

Upon completion of this virtual course, learners should be able to:

  • Demonstrate enhanced medical knowledge and clinical skills across all major areas of endocrinology.
  • Apply knowledge and skills in diagnosing, managing, and treating a wide spectrum of endocrine disorders.
  • Successfully complete the board examination for certification or re-certification in the subspecialty of endocrinology, diabetes, and metabolism.

Additional Information

Target Audience: 
Clinical researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Medical Knowledge
Topic Area: 
Adrenal/HPA Axis
Bone and Calciotropic Hormones
Diabetes and Glucose Metabolism
Lipid Disorders and Fatty Liver Diseases
General Endocrinology
Growth Disorders
Men’s Health
Neuroendocrinology and Pituitary
Thyroid/HPT Axis
Women’s Health
Level of Outcomes: 
Level 1 (Participation)
Activity summary
Available credit: 
  • 21.00 ABIM MOC
  • 21.00 AMA PRA Category 1 Credits
  • 21.00 CME Certificate of Participation
Course opens: 
Course expires: 

Endocrine Board Review 2020 Session Recordings Faculty

Serge A. Jabbour, MD, Program Chair
Professor of Medicine
Director, Division of Endocrinology, Diabetes & Metabolic Diseases
Sidney Kimmel Medical College
Thomas Jefferson University

Andrea D. Coviello, MD
Associate Professor of Medicine
Division of Endocrinology, Metabolism, and Nutrition
Duke University School of Medicine

Natalie Cusano, MD, MS
Associate Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Director of the Bone Metabolism Program
Division of Endocrinology at Lenox Hill Hospital

Tobias Else, MD
Associate Professor
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan

Frances J. Hayes, MB BCh, BAO
Clinical Director
Endocrine Division
Massachusetts General Hospital

Jacqueline Jonklaas, MD, PhD, MPH
Division of Endocrinology
Georgetown University Medical Center

Laurence Katznelson, MD
Professor of Neurosurgery and Medicine
Division of Endocrinology
Stanford University

Michelle F. Magee, MD
MedStar Diabetes, Research and Innovation Institutes
Professor of Medicine
Georgetown University School of Medicine

Kathryn A. Martin, MD
Assistant Professor of Medicine
Harvard Medical School
Practicing Clinician
Massachusetts General Hospital
Senior Physician Editor, Endocrinology and Diabetes

Abbie L. Young, MS, CGC, ELS(D)
Medical Editor

Statement of Independence

As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s guideline task force.

Disclosures Policy

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion. The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

EBR 2020 Faculty Disclosures

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

Natalie Cusano, MD, MS, has served as a consultant to Shire/Takeda and Radius Pharmaceuticals and has served as a speaker for Shire/Takeda and Alexion.

Tobias Else, MD, has served as an advisory board member to Corcept Therapeutics and HRA Pharma, and his institution has received research support from Corcept Therapeutics, Merck and Strongbridge Biopharma.

Serge A. Jabbour, MD, has served as a consultant to AstraZeneca and Janssen, and his institution has received research support from the National Institutes of Health.

Laurence Katznelson, MD, has served as a consultant and principal investigator to Chiasma and Camarus, and he has served as an advisory board member to Novo Nordisk.

Michelle F. Magee, MD, receives research support from the NIH Diabetes Prevention Program Observational Study and the NIH Grade Study as an investigator on behalf of MedStar Health Research Institute. She serves as a speaker for the American Diabetes Association, the American College of Cardiology, and the Endocrine Society.  

Kathryn A. Martin, MD, has served as a physician editor for UpToDate.

The following faculty reported no relevant financial relationships: Andrea D. Coviello, MD; Frances J. Hayes, MB BCh, BAO; and Jacqueline Jonklaas, MD, PhD, MPH

The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.


The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

Use of professional judgment: 
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available.

Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.


The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.


The Endocrine Society will record learner’s personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

Click "Start" to claim CME, MOC, and Certificate of Participation

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates this enduring activity for a maximum of 21 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 21 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Review your Diplomate ABIM ID Number(s)

In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

Provide your board-certification information in your educational profile.
Your profile currently contains the following board ID numbers (must be logged in to view):

My NameI am Certified by the ABIMMy ABIM NumberMy Date of Birth
[current-user:profile-profile:field-first-name] [current-user:profile-profile:field-last-name]




*If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.

Update Profile


Available Credit

  • 21.00 ABIM MOC
  • 21.00 AMA PRA Category 1 Credits
  • 21.00 CME Certificate of Participation

Purchase is required. Purchase Endocrine Board Review 2020 Session Recordings by visiting endocrine.org/store/board-review-products/